Futura Medical (FUM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

34.85p
   
  • Change Today:
    -0.60p
  • 52 Week High: 65.00p
  • 52 Week Low: 25.50p
  • Currency: UK Pounds
  • Shares Issued: 301.45m
  • Volume: 408,913
  • Market Cap: £105.06m
  • RiskGrade: 479

Chairman and CEO of Mediterranean Oil & Gas stock up

Date: Wednesday 09 Jan 2013

LONDON (ShareCast) - Both the Chairman and Chief Executive of Mediterranean Oil & Gas (MOG) increased their holdings in the company on Tuesday, one day after it said it was ‘pleased’ with its production activities in Italy last year, setting the stage for a strong 2013.

CEO William Higgs purchased 200,000 shares at 10.15p each, for a total cost of £20,298, while Chairman Keith Henry bought up 250,000 shares at 10.22p a time for £25,550.

Henry's stake in the group now stands at 1.25m, while Higgs holds 200,000.

The company achieved a total net oil production of 50.68m standing cubic metres (scm) during 2012, representing an average net production of 138,470 scm per day or 872 barrels of oil equivalent per day.

Last year business was boosted after MOG was awarded the Aglavizza Production Concession onshore central Italy where it holds sold ownership in the 7 km2 concession which includes the Civita 1 discovery. It has estimated reserves of more than 1 billion cubic feet (bcf) with first gas expected in early 2015.

In another boon to MOG, offshore restrictions were lifted at Ombrina Mare last August allowing for access to the Sicily oil field's 2P reserves of 40m barrels of oil and 6.5bcf of gas.

In a statement released on Monday Higgs said:"We were pleased with the production performance of our offshore and onshore assets in Italy during 2012, which created steady revenues for the company.

"This production provides a solid base from which to progress our active exploration and production activities in Italy and elsewhere during 2013."


Top Director Buys

Mediterranean Oil & Gas (MOG)
Director name: Mr Keith Henry
Amount purchased: 250,000 @ 10.22p
Value: £25,550

Mediterranean Oil & Gas (MOG)
Director name: Dr. William George Higgs
Amount purchased: 200,000 @ 10.15p
Value: £20,300

Rolls-Royce Holdings (RR.)
Director name: Mr Peter John Byrom
Amount purchased: 1,897 @ 906.21p
Value: £17,191

Futura Medical (FUM)
Director name: Mr John M Clarke
Amount purchased: 20,405 @ 84.10p
Value: £17,161

Anglo American (AAL)
Director name: Mr Peter Woicke
Amount purchased: 908 @ 1,879.75p
Value: £17,068

Anglo American (AAL)
Director name: Mr Phuthuma F. Nhleko
Amount purchased: 739 @ 1,879.75p
Value: £13,891

Anglo American (AAL)
Director name: Ms Anne Stevens
Amount purchased: 711 @ 1,879.75p
Value: £13,365

office2office (OFF)
Director name: Mr Simon Moate
Amount purchased: 10,000 @ 100.00p
Value: £10,000


Top Director Sells

Kingfisher (KGF)
Director name: Mr Euan Sutherland
Amount sold: 45,292 @ 286.60p
Value: £129,807

CML Microsystems (CML)
Director name: Mr Nigel G Clark
Amount sold: 12,900 @ 395.00p
Value: £50,955

NR

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Futura Medical Market Data

Currency UK Pounds
Share Price 34.85p
Change Today -0.60p
% Change -1.69 %
52 Week High 65.00p
52 Week Low 25.50p
Volume 408,913
Shares Issued 301.45m
Market Cap £105.06m
RiskGrade 479

Futura Medical Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
47.72% below the market average47.72% below the market average47.72% below the market average47.72% below the market average47.72% below the market average
17.65% below the sector average17.65% below the sector average17.65% below the sector average17.65% below the sector average17.65% below the sector average
Price Trend
14.35% above the market average14.35% above the market average14.35% above the market average14.35% above the market average14.35% above the market average
60.71% above the sector average60.71% above the sector average60.71% above the sector average60.71% above the sector average60.71% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Futura Medical Dividends

No dividends found

Trades for 29-Apr-2024

Time Volume / Share Price
16:35 9,297 @ 34.85p
16:35 3,064 @ 34.85p
16:35 1,233 @ 34.85p
16:35 703 @ 34.85p
16:35 2,913 @ 34.85p

Futura Medical Key Personnel

CEO James Henry Barder
Finance Director Angela Hildreth

Top of Page